72983-78-9 ((5-Iminodaunorubicin)

CAS号:
72983-78-9
英文名称:
5-Iminodaunorubicin
分子式:
C27H30N2O9
分子量:
526.535108089447
简介:
5-Iminodaunorubicin 是一种醌改性蒽环类活性分子,具有抗肿瘤活性。5-Iminodaunorubicin 在癌细胞中可诱导 DNA 链断裂。

5-Iminodaunorubicin(72983-78-9)名称与标识符

名称

英文别名:
5(8H)-Naphthacenone,8-acetyl-10-[(3-amino-2,3,6-trideoxy-a-L-lyxo-hexopyranosyl)oxy]-7,9,10,12-tetrahydro-6,8,11-trihydroxy-12-imino-1-methoxy-,(8S,10S)-;5(8H)-Naphthacenone, 8-acetyl-10-(3-amino-2,3,6-trideoxy-.alpha.-L-lyxo-hexopyranosyl)oxy-7,9,10,12-tetrahydro-6,8,11-trihydroxy-12-imino-1-methoxy-, (8S,10S)-;5(8H)-Naphthacenone,8-acetyl-10-[(3-amino-2,3,6-trideoxy-a-L-lyxo-hexopyranosyl)oxy]-7,9,10,12-tetrahydro-6,8,11-trihydroxy-1;5-Iminodaunorubicin;NSC254681;UNII-P910685S6G;(8S-cis)-8-Acetyl-10-[(3-amino-2,3,6-trideoxy-.alpha.-L-lyxo-(hexopyranosyl)oxy]-7,9,10,12-tetrahydro-6,8,11-trihydroxy-12-imino-1-methoxy-5(8H)-naphthacenone;72983-78-9;5(8H)-NAPHTHACENONE, 8-ACETYL-10-((3-AMINO-2,3,6-TRIDEOXY-.ALPHA.-L-LYXO-HEXOPYRANOSYL)OXY)-7,9,10,12-TETRAHYDRO-6,8,11-TRIHYDROXY-12-IMINO-1-METHOXY-, (8S,10S)-;PD157779;P910685S6G;BRN 4069837;(8S,10S)-8-ACETYL-10-((3-AMINO-2,3,6-TRIDEOXY-.ALPHA.-L-LYXO-HEXOPYRANOSYL)OXY)-7,9,10,12-TETRAHYDRO-6,8,11-TRIHYDROXY-12-IMINO-1-METHOXY-5(8H)-NAPHTHACENONE;5(8H)-Naphthacenone, 8-acetyl-10-((3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy)-7,9,10,12-tetrahydro-6,8,11-trihydroxy-12-imino-1-methoxy-, (8S-cis)-;NSC-833900;CHEMBL3304020;(8S,10S)-8-acetyl-10-[(2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy-6,8,11-trihydroxy-12-imino-1-methoxy-9,10-dihydro-7H-tetracen-5-one;Q27286385;MS-29746;5-ID;CS-0159974;CCRIS 5676;NSC-254681;HY-138645;(8S,10S)-8-acetyl-10-[(2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyl-tetrahydropyran-2-yl]oxy-6,8,11-trihydroxy-12-imino-1-methoxy-9,10-dihydro-7H-tetracen-5-one;5(8H)-Naphthacenone der.;NSC833900;5-Iminodaunomycin;

标识符

InChIKey:
BLLIIPIJZPKUEG-HPTNQIKVSA-N
Inchi:
1S/C27H30N2O9/c1-10-23(31)14(28)7-17(37-10)38-16-9-27(35,11(2)30)8-13-19(16)26(34)20-21(25(13)33)24(32)12-5-4-6-15(36-3)18(12)22(20)29/h4-6,10,14,16-17,23,29,31,33-35H,7-9,28H2,1-3H3/t10-,14-,16-,17-,23+,27-/m0/s1
SMILES:
O([C@H]1C[C@@H]([C@@H]([C@H](C)O1)O)N)[C@@H]1C2C(=C3C(C4C(=CC=CC=4C(C3=C(C=2C[C@@](C(C)=O)(C1)O)O)=O)OC)=N)O

5-Iminodaunorubicin(72983-78-9)物化性质

实验特性

  • LogP : 2.01410
  • PSA : 192.62000
  • 折射率 : 1.698
  • 沸点 : 864.9°C at 760 mmHg
  • 闪点 : 476.9°C
  • 密度 : 1.51

计算特性

  • 精确分子量 : 526.195
  • 氢键供体数量 : 5
  • 氢键受体数量 : 11
  • 可旋转化学键数量 : 4
  • 同位素质量 : 526.195
  • 重原子数量 : 38
  • 复杂度 : 1030
  • 同位素原子数量 : 0
  • 确定原子立构中心数量 : 6
  • 不确定原子立构中心数量 : 0
  • 确定化学键立构中心数量 : 0
  • 不确定化学键立构中心数量 : 0
  • 共价键单元数量 : 1
  • 疏水参数计算参考值(XlogP) : 1.4
  • 拓扑分子极性表面积 : 192A^2

5-Iminodaunorubicin(72983-78-9)推荐厂家 更多厂家(1)

公司名称手机号/电话联系人QQ微信询单
MedChemExpress(MCE 中国) 13611715263
021-58955995
MCE生命科学试剂 2881321772
询单